Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-000506-78Phase 3Terminated
Phase 3, open-label, single-arm trial of tigecycline in pulmonary infection, sponsored by Hannover Clinical Trial Center. Primary endpoint: Steady-state pharmacokinetics of tigecycline on day 3. Started Mar 2007; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-000506-78.